Allitinib tosylate
CAS: 1050500-29-2
Ref. TM-T6331
| 1mg | 52.00 € | ||
| 5mg | 110.00 € | ||
| 10mg | 174.00 € | ||
| 25mg | 326.00 € | ||
| 50mg | 487.00 € | ||
| 100mg | 692.00 € | ||
| 200mg | 574.00 € | ||
| 1mL*10mM (DMSO) | 153.00 € |
Estimated delivery in United States, on Wednesday 4 Dec 2024
Product Information
Name:
Allitinib tosylate
Synonyms:
- AST-6
- AST-1306 TsOH
- AST-1306 (TsOH)
- AST-1306
- Allitinib
- AST 1306 tosylate
- N-[4-[[3-Chloro-4-[(3-fluorophenyl)methoxy]phenyl]amino]-6-quinazolinyl]-2-propenamide 4-methylbenzenesulfonate
- AST 1306 (p-Toluenesulfonic acid)
Description:
Allitinib tosylate (AST-1306) is a novel irreversible inhibitor of EGFR and ErbB2 with IC50 of 0.5 nM and 3 nM, respectively.
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Targetmol
Long term storage:
Notes:
Chemical properties
Molecular weight:
621.08
Formula:
C31H26ClFN4O5S
Purity:
98.46% - 98.52%
Color/Form:
Solid
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: TM-T6331 Allitinib tosylate
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
